| |
Asthma
|
Asthma + atopic dermatitis
|
P value
|
|---|
|
n
|
13
|
9
| |
|
Age (years)
|
47.5 ± 14.8
|
38.1 ± 11.3
|
0.127
|
|
Sex /female)
|
10/13 77%
|
6/9 67%
|
0.394
|
|
IgE
|
212 ± 224
|
3528 ± 2723
|
< 0.001
|
|
FEV1
|
71.5 ± 10,7
|
76.2 ± 7,4
|
0.350
|
|
Weight in kg
|
82.3 ± 22.0
|
76.3 ± 16.1
|
0.472
|
|
Omalizumab dosage
| | | |
|
(mg/2 weeks)
|
213 ± 86
|
233 ± 109
|
0.654
|
|
OCS baseline
|
12/13
|
7/9
|
0.394
|
|
OCS 6 month
|
4/13
|
0/9
|
0.003
|
|
OCS 12 month
|
4/13
|
0/9
|
0.003
|
|
AQlQ baseline
|
102 ± 40
|
143 ± 44
|
0.041
|
|
AQlQ 6 month
|
148 ± 48
|
175 ± 40
|
0.041
|
|
AQlQ 12 month
|
152 ± 45
|
170 ± 42
|
0.04
|
|
DlQI baseline
| |
19 ± 10
| |
|
DlQI 6 month
| |
7 ± 8
| |
|
DlQI 12 moth
| |
6 ± 6
| |
- OCS, oral corticosteroids, ICS, inhaled corticosteroids.
